Aytu Biopharma (AYTU) Free Cash Flow (2010 - 2026)
Aytu Biopharma (AYTU) reported Free Cash Flow of -$4.2 million for Q1 2026, up 35.9% year-over-year from -$3.1 million in Q1 2025, and down 214.32% quarter-over-quarter from $3.7 million in Q4 2025.
Aytu Biopharma (AYTU) Free Cash Flow (2010 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has 17 years of Free Cash Flow data on file, last reported at -$4.2 million in Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$4.2 million, up 35.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (up 127.09% YoY), and the FY2025 annual result was -$2.2 million, down 26.09% from the prior year.
- Free Cash Flow retreated to -$4.2 million in Q1 2026 per AYTU's latest filing, from $3.7 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $9.4 million in Q2 2023 and troughed at -$9.1 million in Q1 2022.
- A 5-year average of -$1.6 million and a median of -$1.1 million in 2024 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2024 and 2025: Free Cash Flow surged 2247.41% in 2024, then tumbled 2468.5% in 2025.
- A 5-year view of Free Cash Flow shows it stood at -$2.5 million in 2022, then surged by 94.6% to -$135000.0 in 2023, then surged by 2247.41% to $2.9 million in 2024, then gained by 26.18% to $3.7 million in 2025, then tumbled by 214.32% to -$4.2 million in 2026.
- Business Quant data shows AYTU's Free Cash Flow at -$4.2 million in Q1 2026, $3.7 million in Q4 2025, and -$618000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | Aytu Biopharma | 24.60 Mn | -2.12 Mn | 7.60 Mn | -4.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.18 Mn |
| Mar 31, 2026 | -4.18 Mn |
| Dec 31, 2025 | 3.66 Mn |
| Dec 31, 2025 | 3.66 Mn |
| Sep 30, 2025 | -618,000.00 |
| Sep 30, 2025 | -618,000.00 |
| Jun 30, 2025 | 2.79 Mn |
| Jun 30, 2025 | 2.79 Mn |
| Mar 31, 2025 | -6.52 Mn |
| Mar 31, 2025 | -6.52 Mn |
| Dec 31, 2024 | 2.90 Mn |
| Dec 31, 2024 | 2.90 Mn |
| Sep 30, 2024 | -1.33 Mn |
| Sep 30, 2024 | -1.33 Mn |
| Jun 30, 2024 | -1.12 Mn |
| Jun 30, 2024 | -1.12 Mn |
| Mar 31, 2024 | -254,000.00 |
| Mar 31, 2024 | -254,000.00 |
| Dec 31, 2023 | -135,000.00 |
| Dec 31, 2023 | -135,000.00 |